A detailed history of Citigroup Inc transactions in Incyte Corp stock. As of the latest transaction made, Citigroup Inc holds 166,550 shares of INCY stock, worth $11.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
166,550
Previous 291,185 42.8%
Holding current value
$11.6 Million
Previous $17.7 Million 37.64%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$57.33 - $68.61 $7.15 Million - $8.55 Million
-124,635 Reduced 42.8%
166,550 $11 Million
Q2 2024

Aug 12, 2024

SELL
$51.18 - $63.75 $6.92 Million - $8.62 Million
-135,146 Reduced 31.7%
291,185 $17.7 Million
Q1 2024

May 10, 2024

SELL
$56.55 - $66.59 $3.52 Million - $4.15 Million
-62,253 Reduced 12.74%
426,331 $24.3 Million
Q4 2023

Feb 09, 2024

SELL
$52.16 - $64.19 $1.31 Million - $1.62 Million
-25,202 Reduced 4.91%
488,584 $30.7 Million
Q3 2023

Nov 09, 2023

BUY
$57.77 - $65.93 $10 Million - $11.4 Million
173,412 Added 50.95%
513,786 $29.7 Million
Q2 2023

Aug 10, 2023

SELL
$60.95 - $75.51 $9.73 Million - $12.1 Million
-159,586 Reduced 31.92%
340,374 $21.2 Million
Q1 2023

May 11, 2023

BUY
$70.23 - $86.01 $12.7 Million - $15.6 Million
181,496 Added 56.99%
499,960 $36.1 Million
Q4 2022

Feb 09, 2023

SELL
$67.18 - $84.11 $4.43 Million - $5.54 Million
-65,914 Reduced 17.15%
318,464 $25.6 Million
Q3 2022

Nov 10, 2022

BUY
$66.18 - $82.86 $12.7 Million - $15.9 Million
191,932 Added 99.73%
384,378 $25.6 Million
Q2 2022

Aug 10, 2022

SELL
$66.18 - $83.18 $298,471 - $375,141
-4,510 Reduced 2.29%
192,446 $14.6 Million
Q1 2022

May 12, 2022

BUY
$66.02 - $79.71 $2.83 Million - $3.42 Million
42,930 Added 27.87%
196,956 $15.6 Million
Q4 2021

Feb 10, 2022

SELL
$63.34 - $74.11 $4.59 Million - $5.37 Million
-72,526 Reduced 32.01%
154,026 $11.3 Million
Q3 2021

Nov 10, 2021

BUY
$68.67 - $84.02 $15.6 Million - $19 Million
226,552 New
226,552 $15.6 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.